Invention Grant
US09072797B2 Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies
有权
人类CD66用于治疗多发性骨髓瘤和其他血液恶性肿瘤的免疫偶联物
- Patent Title: Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies
- Patent Title (中): 人类CD66用于治疗多发性骨髓瘤和其他血液恶性肿瘤的免疫偶联物
-
Application No.: US12097508Application Date: 2006-11-30
-
Publication No.: US09072797B2Publication Date: 2015-07-07
- Inventor: Ivan Benes , Klaus Bosslet , Kim Orchard
- Applicant: Ivan Benes , Klaus Bosslet , Kim Orchard
- Applicant Address: CH Zug
- Assignee: THERAPHARM GMBH
- Current Assignee: THERAPHARM GMBH
- Current Assignee Address: CH Zug
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/EP2006/011533 WO 20061130
- International Announcement: WO2007/062855 WO 20070607
- Main IPC: A61K51/10
- IPC: A61K51/10 ; A61K47/48 ; C07K16/28
Abstract:
The present invention relates to the use of radioimmunoconjugates for the treatment of haematological malignancies, particularly multiple myeloma.
Public/Granted literature
Information query
